All Stories

  1. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis
  2. The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy
  3. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis
  4. Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
  5. Donor‐derived renal allograft mucormycosis in a combined liver and kidney transplantation: Case report and review of the literature
  6. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis (Preprint)
  7. Central Asia SARS-CoV-2 Surveillance: A Longitudinal Trend Analysis (Preprint)
  8. Central Asia SARS-CoV-2 Surveillance: A Longitudinal Trend Analysis (Preprint)
  9. Canada SARS-CoV-2 Surveillance System: Longitudinal Trend Analysis (Preprint)
  10. Latin America and the Caribbean SARS-Cov-2 Surveillance: Longitudinal Trend Analysis (Preprint)
  11. European SARS-CoV-2 Surveillance: Longitudinal Trend Analyses of Wave Two (Preprint)
  12. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis (Preprint)
  13. Dynamic Metrics for Public Health Surveillance Are Imperative to Gain Control of the COVID-19 Pandemic in America: Longitudinal Trend Analysis (Preprint)
  14. Would the US Benefit from a President Wilson or Roosevelt Response to COVID-19: Longitudinal Trend Analysis of Static and Dynamic Surveillance Metrics (Preprint)
  15. Treatment of multidrug‐resistant gram‐negative bacilli after solid organ transplant: Outcomes and complications
  16. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients
  17. Ibrutinib for chronic lymphocytic leukemia in the setting of respiratory failure from severe COVID‐19 infection: Case report and literature review
  18. Ten years of donor‐derived disease: A report of the disease transmission advisory committee
  19. A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study
  20. A Unique Clade of SARS-CoV-2 Viruses is Associated with Lower Viral Loads in Patient Upper Airways
  21. Utilization of deceased organ donors based on HIV, hepatitis B virus, and hepatitis C virus screening test results
  22. Optimizing Use of Antibiotics and Antivirals in Ambulatory Patients With Influenza
  23. Impact of theOPTNtransmissible diseases policy andUS PHSincreased risk donor guidelines on living donor candidates
  24. Pre‐ and post‐transplant bacterial infections in liver transplant recipients
  25. Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6‐year retrospective study
  26. Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: A single center, retrospective study
  27. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes
  28. Appropriateness of Beta-Lactam Allergy Record Updates After an Allergy Service Consult
  29. Parainfluenza Virus in Hospitalized Adults: A 7-Year Retrospective Study
  30. Influenza in Transplant Recipients: Many Outstanding Questions Despite a Growing Body of Data
  31. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation
  32. Screening recipients of increased risk donor organs: A multicenter retrospective study
  33. Safety and efficacy of foscarnet for the management of ganciclovir-resistant or refractory cytomegalovirus infections: A single-center study
  34. Impact of electronic health record-based, pharmacist-driven valganciclovir dose optimization in solid organ transplant recipients
  35. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results
  36. The challenge of urinary tract infections in renal transplant recipients
  37. The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation
  38. A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation
  39. Norovirus infection in solid organ transplant recipients: a single-center retrospective study
  40. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative
  41. Opportunistic infections complicating solid organ transplantation with alemtuzumab induction
  42. Optimizing antiviral therapy for influenza: understanding the evidence
  43. Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital
  44. BK Virus Replication and Nephropathy After Alemtuzumab-Induced Kidney Transplantation
  45. Antimicrobial Drug-Induced Thrombocytopenia: A Review of the Literature
  46. Preventable Errors in Organ Transplantation: An Emerging Patient Safety Issue?
  47. Antiviral therapies for respiratory viral infections in lung transplant patients
  48. Diagnosis, management and outcomes of adults hospitalized with influenza
  49. Uniform Definitions for Donor-Derived Infectious Disease Transmissions in Solid Organ Transplantation
  50. Influenza in pediatric solid-organ transplant recipients
  51. Antivirals and resistance: influenza virus
  52. Organ transplantation from deceased donors with cancer: is it safe?
  53. Editorial [Hot topic: Infectious Diseases and Hematology: At the Crossroad of Contemporary Therapy (Guest Editors: Hau C. Kwaan and Michael G. Ison)]
  54. Influenza, including the novel H1N1, in organ transplant patients
  55. Difficult cases in immunocompromised patients
  56. Donor derived transmission events in the us: a case-based discussion
  57. Respiratory infections and antimicrobial resistance – new challenges
  58. Respiratory infections in the immunocompromised host
  59. Anti-influenza therapy: the emerging challenge of resistance
  60. Influenza in Hospitalized Adults: Gaining Insight into a Significant Problem
  61. The Epidemiology and Prevention of Donor-Derived Infections
  62. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation
  63. Development of BK Nephropathy in Recipients of Simultaneous Pancreas-Kidney Transplantation
  64. Emerging Infections: Adenovirus Infections in Transplant Recipients
  65. Respiratory viral infections in transplant recipients